NEW YORK, March 17 The latest advancement in facial contouring, the AccuLift(TM) procedure, was just featured on CBS' The Early Show. New York physician Dr. Jon Turk introduced the breakthrough treatment to millions of viewers as the bridge between facial fillers and surgical facelifts.
Advertisement
As Dr. Turk explained, people looking to reverse the signs of aging want more for less: less surgery, less anesthesia, less recovery - all for less money - and AccuLift treatment delivers on each of these fronts.
Advertisement
The AccuLift procedure works by sculpting and tightening the skin of the lower face without losing volume in the upper face, changing the "pear" shape typical of aging adults to the "apple" shape typical of youth. It gently and precisely removes excess fat deposits that have migrated downward in the face, leaving behind tighter, sculpted features in just 30 minutes or less.
The segment's dramatic before-and-after images showed a patient with deep nasolabial folds prior to the treatment, and their dramatic absence post-treatment; the sagging chin of a middle-aged man, and his sculpted appearance post-treatment; and the live reveal of a patient's tightened jowls post-procedure. To learn more about the AccuLift procedure results, please watch the segment and follow the link below: http://www.cbsnews.com/video/watch/?id=6288847n
Created by worldwide aesthetic innovator Lutronic, a leading developer and manufacturer of medical laser systems for dermatological and aesthetic surgery applications, the AccuLift procedure was developed to meet the needs of patients who are seeking immediate, significant, lasting results with minimal downtime for problem areas such as sagging cheeks and jowls, heavy smile lines, and loose skin and excess fat under the chin.
For more information, log on to www.acculiftnow.com.
About Lutronic
Lutronic is a leading developer and manufacturer of medical laser systems for dermatological and aesthetic surgery applications. In addition to the AccuSculpt device, the Company's advanced technologies include the eCO2 fractional laser, the Spectra Q-Switched Nd:YAG laser and the unparalleled MOSAIC fractional system. With distribution in over 47 countries and more than a decade of award-winning advances in research and development, Lutronic is committed to delivering innovative, highly effective and versatile laser solutions at exceptional value. Dedicated customer care and clinician support worldwide are a primary focus at Lutronic. To learn more about the company's portfolio of laser systems, please visit www.lutronic.com.
SOURCE Lutronic
